Atsushi Kumanogoh Selected Research

Respiratory Insufficiency (Respiratory Failure)

7/2021	Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19.
1/2015	Dapsone hypersensitivity syndrome-related lung injury without eosinophilia in the bronchoalveolar lavage fluid.
11/2014	Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Kumanogoh Research Topics

Disease

69	Neoplasms (Cancer) 04/2024 - 01/2007
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2012
24	Rheumatoid Arthritis 07/2023 - 01/2012
22	Inflammation (Inflammations) 01/2024 - 04/2007
19	COVID-19 04/2023 - 01/2021
11	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2013
11	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 08/2002
10	Fibrosis (Cirrhosis) 01/2024 - 07/2012
9	Arthritis (Polyarthritis) 01/2023 - 01/2012
8	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2008
8	Multiple Sclerosis 08/2021 - 08/2008
7	Disease Progression 01/2024 - 01/2014
7	Pneumonia (Pneumonitis) 11/2023 - 01/2013
6	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2011
6	Infections 01/2023 - 01/2020
6	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2022 - 10/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 04/2012
6	Leukemia 01/2016 - 12/2012
5	Hypoxia (Hypoxemia) 01/2024 - 05/2015
5	Hypersensitivity (Allergy) 01/2023 - 07/2009
5	Neuromyelitis Optica (Devic's Disease) 01/2022 - 03/2009
5	Emphysema 01/2022 - 10/2013
4	Rhinosinusitis 03/2024 - 01/2019
4	Asthma (Bronchial Asthma) 03/2024 - 01/2013
4	Idiopathic Pulmonary Fibrosis 01/2024 - 01/2014
4	Systemic Scleroderma (Systemic Sclerosis) 09/2023 - 01/2015
4	Rheumatic Diseases (Rheumatism) 07/2023 - 01/2018
4	Necrosis 01/2023 - 03/2009
4	Adenocarcinoma of Lung 01/2022 - 01/2012
4	Psoriatic Arthritis 05/2021 - 01/2012
4	Fever (Fevers) 05/2021 - 01/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2012
4	Vasculitis (Vasculitides) 01/2020 - 08/2017
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020 - 08/2017
4	Carcinogenesis 11/2016 - 06/2006
3	Bites and Stings (Sting) 04/2024 - 10/2018
3	Sepsis (Septicemia) 08/2023 - 01/2022
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 01/2018
3	Hypertension (High Blood Pressure) 01/2022 - 01/2013
3	Idiopathic Interstitial Pneumonias 01/2022 - 10/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2011
3	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 11/2014
3	Lung Diseases (Lung Disease) 01/2021 - 01/2013
3	Colitis 01/2021 - 02/2012
3	Osteoporosis 01/2021 - 03/2013
3	Pulmonary Hypertension 01/2021 - 05/2015
3	Bone Resorption 01/2021 - 01/2011
3	Pulmonary Alveolar Proteinosis 01/2021 - 11/2014

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2010
20	Semaphorins (Semaphorin)IBA 02/2024 - 06/2006
20	Peptides (Polypeptides)IBA 01/2023 - 08/2002
18	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2016
17	Immune Checkpoint InhibitorsIBA 04/2024 - 08/2018
16	AntigensIBA 01/2022 - 04/2007
13	VaccinesIBA 03/2023 - 02/2014
12	CD100 antigenIBA 01/2020 - 01/2007
10	AutoantibodiesIBA 02/2022 - 03/2009
9	Immunoglobulin G (IgG)IBA 03/2023 - 03/2009
9	CytokinesIBA 01/2017 - 04/2007
8	AntibodiesIBA 01/2023 - 04/2016
8	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2018
8	Protein Subunit VaccinesIBA 01/2022 - 07/2015
7	InterferonsIBA 04/2024 - 12/2012
7	EpitopesIBA 01/2023 - 12/2012
7	Monoclonal AntibodiesIBA 01/2022 - 10/2002
6	NivolumabIBA 04/2024 - 10/2018
6	GlucocorticoidsIBA 01/2024 - 01/2017
6	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2020
6	Messenger RNA (mRNA)IBA 01/2023 - 07/2015
6	TetraspaninsIBA 01/2020 - 07/2012
6	WT1 ProteinsIBA 11/2018 - 03/2012
5	Therapeutic UsesIBA 01/2024 - 01/2017
5	Janus Kinase InhibitorsIBA 07/2023 - 01/2020
5	SteroidsIBA 04/2023 - 01/2017
5	Cancer VaccinesIBA 01/2023 - 02/2014
5	Tyrosine Kinase InhibitorsIBA 01/2023 - 02/2017
5	tocilizumab (atlizumab)FDA Link 09/2020 - 01/2012
5	Interleukin-17 (Interleukin 17)IBA 03/2020 - 05/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2004
4	Granzymes (Granzyme)IBA 04/2024 - 04/2013
4	pembrolizumabIBA 01/2024 - 01/2019
4	ProteomeIBA 01/2024 - 12/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 01/2012
4	mRNA VaccinesIBA 03/2023 - 03/2022
4	HLA-A*24:02 antigenIBA 01/2023 - 12/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
4	LigandsIBA 01/2021 - 01/2019
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 11/2014
4	Myelin-Oligodendrocyte GlycoproteinIBA 04/2011 - 08/2002
3	Complement System Proteins (Complement)IBA 01/2024 - 03/2009
3	Mitochondrial DNA (mtDNA)IBA 10/2023 - 04/2018
3	Abatacept (Orencia)FDA Link 03/2023 - 09/2020
3	Neutralizing AntibodiesIBA 03/2023 - 04/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2020
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 10/2013

Therapy/Procedure

32	Therapeutics 11/2023 - 05/2010
29	Immunotherapy 04/2024 - 05/2011
13	Drug Therapy (Chemotherapy) 01/2024 - 01/2012
3	Chemoradiotherapy 05/2023 - 01/2019